{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:23:27Z","timestamp":1792041807577,"version":"4.4.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008131","name":"Rheinische Friedrich-Wilhelms-Universit\u00e4t Bonn","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008131","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite the importance of drug release testing of parenteral depot formulations, the current <jats:italic>in vitro<\/jats:italic> methods still require ameliorations in biorelevance. We have investigated here the use of muscle tissue components to better mimic the intramuscular administration. For convenient handling, muscle tissue was used in form of a freeze-dried powder, and a reproducible process of incorporation of tested microspheres to an assembly of muscle tissue of standardized dimensions was successfully developed. Microspheres were prepared from various grades of poly(lactic-co-glycolic acid) (PLGA) or ethyl cellulose, entrapping flurbiprofen, lidocaine, or risperidone. The deposition of microspheres in the muscle tissue or addition of only isolated lipids into the medium accelerated the release rate of all model drugs from microspheres prepared from ester-terminated PLGA grades and ethyl cellulose, however, not from the acid-terminated PLGA grades. The addition of lipids into the release medium increased the solubility of all model drugs; nonetheless, also interactions of the lipids with the polymer matrix (ad- and absorption) might be responsible for the faster drug release. As the <jats:italic>in vivo<\/jats:italic> drug release from implants is also often faster than in simple buffers <jats:italic>in vitro<\/jats:italic>, these findings suggest that interactions with the tissue lipids may play an important role in these still unexplained observations.<\/jats:p>","DOI":"10.1208\/s12249-021-01965-4","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T17:02:56Z","timestamp":1617037376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Muscle Tissue as a Surrogate for In Vitro Drug Release Testing of Parenteral Depot Microspheres"],"prefix":"10.1208","volume":"22","author":[{"given":"Jan","family":"Kozak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miloslava","family":"Rabiskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alf","family":"Lamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"1965_CR1","doi-asserted-by":"publisher","unstructured":"Martinez MN, Rathbone MJ, Burgess D, Huynh M. Breakout session summary from AAPS\/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products. J Control Release. 2010;142(1):2\u20137.\u00a0https:\/\/doi.org\/10.1016\/j.jconrel.2009.09.028.","DOI":"10.1016\/j.jconrel.2009.09.028"},{"key":"1965_CR2","doi-asserted-by":"publisher","unstructured":"Martinez M, Rathbone M, Burgess D, Huynh M. In vitro and in vivo considerations associated with parenteral sustained release products: A review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting. J Control Release. 2008;129(2):79\u201387.\u00a0https:\/\/doi.org\/10.1016\/j.jconrel.2008.04.004.","DOI":"10.1016\/j.jconrel.2008.04.004"},{"key":"1965_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s11095-005-9397-8","volume":"23","author":"SS D\u2019Souza","year":"2006","unstructured":"D\u2019Souza SS, De Luca PP. Methods to assess in vitro drug release from injectable polymeric particulate systems. Pharm Res. 2006;23:460\u201374 [cited 2019 Mar 27]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16400516.","journal-title":"Pharm Res"},{"key":"1965_CR4","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/j.2042-7158.2011.01439.x","volume":"64","author":"A Seidlitz","year":"2012","unstructured":"Seidlitz A, Weitschies W. In-vitro dissolution methods for controlled release parenterals and their applicability to drug-eluting stent testing. J Pharm Pharmacol. 2012;64:969\u201385 [cited 2019 Mar 27]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22686343.","journal-title":"J Pharm Pharmacol"},{"key":"1965_CR5","doi-asserted-by":"publisher","unstructured":"Pestieau A, Evrard B. In vitro biphasic dissolution tests and their suitability for establishing in vitro-in vivo correlations: A historical review. Eur J Pharm Sci. 2017;102:203\u201319.\u00a0https:\/\/doi.org\/10.1016\/j.ejps.2017.03.019.","DOI":"10.1016\/j.ejps.2017.03.019"},{"key":"1965_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1874126601004020002","volume":"4","author":"N Fotaki","year":"2010","unstructured":"Fotaki N, Vertzoni M. Biorelevant dissolution methods and their applications in in vitro-in vivo correlations for oral formulations. Open Drug Deliv J. 2010;4:2\u201313.","journal-title":"Open Drug Deliv J"},{"key":"1965_CR7","doi-asserted-by":"crossref","unstructured":"Klein S. The use of biorelevant dissolution media to forecast the in vivo performance of a drug. AAPS J. 2010 [cited 2020 Aug 10]. p. 397\u2013406. Available from: \/pmc\/articles\/PMC2895438\/?report=abstract","DOI":"10.1208\/s12248-010-9203-3"},{"key":"1965_CR8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jpba.2006.08.023","volume":"43","author":"SS Iyer","year":"2007","unstructured":"Iyer SS, Barr WH, Karnes HT. Characterization of a potential medium for \u201cbiorelevant\u201d in vitro release testing of a naltrexone implant, employing a validated stability-indicating HPLC method. J Pharm Biomed Anal. 2007;43:845\u201353.","journal-title":"J Pharm Biomed Anal"},{"key":"1965_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jconrel.2015.07.016","volume":"214","author":"HM Kinnunen","year":"2015","unstructured":"Kinnunen HM, Sharma V, Contreras-Rojas LR, Yu Y, Alleman C, Sreedhara A, et al. A novel in vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation components. J Control Release. 2015;214:94\u2013102 [cited 2019 Mar 27]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26210441.","journal-title":"J Control Release"},{"key":"1965_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejpb.2019.03.019","volume":"139","author":"G Magri","year":"2019","unstructured":"Magri G, Selmin F, Cilurzo F, Fotaki N. Biorelevant release testing of biodegradable microspheres intended for intra-articular administration. Eur J Pharm Biopharm. 2019;139:115\u201322.","journal-title":"Eur J Pharm Biopharm"},{"key":"1965_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijpharm.2013.11.031","volume":"461","author":"B Sterner","year":"2014","unstructured":"Sterner B, Harms M, Weigandt M, Windbergs M, Lehr CM. Crystal suspensions of poorly soluble peptides for intra-articular application: A novel approach for biorelevant assessment of their in vitro release. Int J Pharm. 2014;461:46\u201353.","journal-title":"Int J Pharm"},{"key":"1965_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jmbbm.2013.12.009","volume":"32","author":"AM Smith","year":"2014","unstructured":"Smith AM, Fleming L, Wudebwe U, Bowen J, Grover LM. Development of a synovial fluid analogue with bio-relevant rheology for wear testing of orthopaedic implants. J Mech Behav Biomed Mater. 2014;32:177\u201384.","journal-title":"J Mech Behav Biomed Mater"},{"key":"1965_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jpba.2017.11.065","volume":"150","author":"Y Sun","year":"2018","unstructured":"Sun Y, Jensen H, Petersen NJ, Larsen SW, \u00d8stergaard J. Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV\u2013vis imaging. J Pharm Biomed Anal. 2018;150:95\u2013106.","journal-title":"J Pharm Biomed Anal"},{"key":"1965_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jpba.2012.07.024","volume":"71","author":"F Ye","year":"2012","unstructured":"Ye F, Larsen SW, Yaghmur A, Jensen H, Larsen C, \u00d8stergaard J. Drug release into hydrogel-based subcutaneous surrogates studied by UV imaging. J Pharm Biomed Anal. 2012;71:27\u201334.","journal-title":"J Pharm Biomed Anal"},{"key":"1965_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s11095-008-9747-4","volume":"26","author":"D Klose","year":"2009","unstructured":"Klose D, Azaroual N, Siepmann F, Vermeersch G, Siepmann J. Towards more realistic in vitro release measurement techniques for biodegradable microparticles. Pharm Res. 2009;26:691\u20139.","journal-title":"Pharm Res"},{"key":"1965_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jconrel.2009.10.030","volume":"142","author":"F Brandl","year":"2010","unstructured":"Brandl F, Kastner F, Gschwind RM, Blunk T, Te\u00dfmar J, G\u00f6pferich A. Hydrogel-based drug delivery systems: Comparison of drug diffusivity and release kinetics. J Control Release. 2010;142:221\u20138.","journal-title":"J Control Release"},{"key":"1965_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejps.2015.10.011","volume":"81","author":"SS Jensen","year":"2016","unstructured":"Jensen SS, Jensen H, M\u00f8ller EH, Cornett C, Siepmann F, Siepmann J, et al. In vitro release studies of insulin from lipid implants in solution and in a hydrogel matrix mimicking the subcutis. Eur J Pharm Sci. 2016;81:103\u201312.","journal-title":"Eur J Pharm Sci"},{"key":"1965_CR18","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1021\/js9703986","volume":"87","author":"S Allababidi","year":"1998","unstructured":"Allababidi S, Shah JC. Kinetics and Mechanism of Release from Glyceryl Monostearate-Based Implants: Evaluation of Release in a Gel Simulating in Vivo Implantation. J Pharm Sci. 1998;87:738\u201344 [cited 2019 May 20]. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915505820.","journal-title":"J Pharm Sci"},{"key":"1965_CR19","doi-asserted-by":"publisher","first-page":"120142","DOI":"10.1016\/j.ijpharm.2020.120142","volume":"594","author":"J Kozak","year":"2020","unstructured":"Kozak J, Rabiskova M, Lamprecht A. In-vitro drug release testing of parenteral formulations via an agarose gel envelope to closer mimic tissue firmness. Int J Pharm. 2020;594:120142.","journal-title":"Int J Pharm"},{"key":"1965_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jconrel.2014.03.011","volume":"182","author":"HM Kinnunen","year":"2014","unstructured":"Kinnunen HM, Mrsny RJ. Improving the outcomes of biopharmaceutical delivery via the subcutaneous route by understanding the chemical, physical and physiological properties of the subcutaneous injection site. J Control Release. 2014;182:22\u201332 [cited 2019 Mar 27]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S016836591400145X?via%3Dihub.","journal-title":"J Control Release"},{"key":"1965_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jconrel.2008.01.004","volume":"127","author":"BS Zolnik","year":"2008","unstructured":"Zolnik BS, Burgess DJ. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Control Release. 2008;127:137\u201345.","journal-title":"J Control Release"},{"key":"1965_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","volume":"415","author":"S Fredenberg","year":"2011","unstructured":"Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems - a review. Int J Pharm. 2011;415:34\u201352.","journal-title":"Int J Pharm"},{"key":"1965_CR23","doi-asserted-by":"publisher","unstructured":"Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 2012;64:72\u201382.\u00a0https:\/\/doi.org\/10.1016\/j.addr.2012.09.004.","DOI":"10.1016\/j.addr.2012.09.004"},{"key":"1965_CR24","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jddst.2019.03.029","volume":"51","author":"Y Fang","year":"2019","unstructured":"Fang Y, Zhang N, Li Q, Chen J, Xiong S, Pan W. Characterizing the release mechanism of donepezil-loaded PLGA microspheres in vitro and in vivo. J Drug Deliv Sci Technol. 2019;51:430\u20137.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1965_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jconrel.2017.03.031","volume":"256","author":"AC Doty","year":"2017","unstructured":"Doty AC, Weinstein DG, Hirota K, Olsen KF, Ackermann R, Wang Y, et al. Mechanisms of in vivo release of triamcinolone acetonide from PLGA microspheres. J Control Release. 2017;256:19\u201325 [cited 2019 Feb 25]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0168365917301426.","journal-title":"J Control Release"},{"key":"1965_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijpharm.2012.05.006","volume":"434","author":"A Rawat","year":"2012","unstructured":"Rawat A, Bhardwaj U, Burgess DJ. Comparison of in vitro\u2013in vivo release of Risperdal\u00ae Consta\u00ae microspheres. Int J Pharm. 2012;434:115\u201321 [cited 2019 Feb 23]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0378517312004620.","journal-title":"Int J Pharm"},{"key":"1965_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/pi.1697","volume":"54","author":"F Alexis","year":"2005","unstructured":"Alexis F. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]. Polym Int. 2005;54:36\u201346 [cited 2019 Jun 9]. Available from: http:\/\/doi.wiley.com\/10.1002\/pi.1697.","journal-title":"Polym Int"},{"key":"1965_CR28","doi-asserted-by":"publisher","unstructured":"Sharma CP, Williams DF. The effects of lipids on the mechanical properties of polyglycolic acid sutures. Eng Med. 1981;10(1):8\u201310. https:\/\/doi.org\/10.1243\/EMED_JOUR_1981_010_005_02.","DOI":"10.1243\/EMED_JOUR_1981_010_005_02"},{"key":"1965_CR29","doi-asserted-by":"publisher","unstructured":"Cuddihy EF, Moacanin J, Roschke EJ, Harrison EC. In vivo degradation of silicone rubber poppets in prosthetic heart valves. J Biomed Mater Res. 1976;10(3):471\u201381. https:\/\/doi.org\/10.1002\/jbm.820100314.","DOI":"10.1002\/jbm.820100314"},{"key":"1965_CR30","doi-asserted-by":"publisher","unstructured":"Abd E, Yousef SA, Pastore MN, Telaprolu K, Mohammed YH, Namjoshi S, et al. Skin models for the testing of transdermal drugs. Clin Pharmacol Adv Appl. 2016;8:163\u201376.\u00a0https:\/\/doi.org\/10.2147\/CPAA.S64788.","DOI":"10.2147\/CPAA.S64788"},{"key":"1965_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-0846.2006.00179.x","volume":"13","author":"U Jacobi","year":"2007","unstructured":"Jacobi U, Kaiser M, Toll R, Mangelsdorf S, Audring H, Otberg N, et al. Porcine ear skin: An in vitro model for human skin. Skin Res Technol. 2007;13:19\u201324 [cited 2020 Aug 20]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17250528\/.","journal-title":"Skin Res Technol"},{"key":"1965_CR32","first-page":"6","volume":"11","author":"B Chung","year":"2018","unstructured":"Chung B, Lee H, Choi M, Seo KY, Kim EK, Kim TI. Preloaded and non-preloaded intraocular lens delivery system and characteristics: Human and porcine eyes trial. Int J Ophthalmol. 2018;11:6\u201311 [cited 2020 Sep 10]. Available from: \/pmc\/articles\/PMC5767650\/?report=abstract.","journal-title":"Int J Ophthalmol"},{"key":"1965_CR33","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1016\/j.xphs.2018.08.013","volume":"107","author":"H Shelley","year":"2018","unstructured":"Shelley H, Rodriguez-Galarza RM, Duran SH, Abarca EM, Babu RJ. In Situ Gel Formulation for Enhanced Ocular Delivery of Nepafenac. J Pharm Sci. 2018;107:3089\u201397.","journal-title":"J Pharm Sci"},{"key":"1965_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejps.2012.05.007","volume":"47","author":"C Loch","year":"2012","unstructured":"Loch C, Zakelj S, Kristl A, Nagel S, Guthoff R, Weitschies W, et al. Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes. Eur J Pharm Sci. 2012;47:131\u20138.","journal-title":"Eur J Pharm Sci"},{"key":"1965_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jconrel.2015.09.051","volume":"218","author":"J Shen","year":"2015","unstructured":"Shen J, Choi S, Qu W, Wang Y, Burgess DJ. In vitro-in vivo correlation of parenteral risperidone polymeric microspheres. J Control Release. 2015;218:2\u201312.","journal-title":"J Control Release"},{"key":"1965_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7243\/2050-120X-2-19","volume":"2","author":"B Semmling","year":"2013","unstructured":"Semmling B, Nagel S, Sternberg K, Weitschies W, Seidlitz A. Long-term stable hydrogels for biorelevant dissolution testing of drug-eluting stents. J Pharm Technol Drug Res. 2013;2:19 [cited 2019 Mar 28]. Available from: http:\/\/www.hoajonline.com\/jptdr\/2050-120X\/2\/19.","journal-title":"J Pharm Technol Drug Res"},{"key":"1965_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jconrel.2006.08.006","volume":"115","author":"S Liang","year":"2006","unstructured":"Liang S, Xu J, Weng L, Dai H, Zhang X, Zhang L. Protein diffusion in agarose hydrogel in situ measured by improved refractive index method. J Control Release. 2006;115:189\u201396.","journal-title":"J Control Release"},{"key":"1965_CR38","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1021\/bm800571s","volume":"9","author":"RW Sirianni","year":"2008","unstructured":"Sirianni RW, Kremer J, Guler I, Chen Y-L, Keeley FW, Saltzman WM. Effect of extracellular matrix elements on the transport of paclitaxel through an arterial wall tissue mimic. Biomacromolecules. 2008;9:2792\u20138 [cited 2019 May 12]. Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/bm800571s.","journal-title":"Biomacromolecules"},{"key":"1965_CR39","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1208\/s12249-016-0698-5","volume":"18","author":"DH Leung","year":"2017","unstructured":"Leung DH, Kapoor Y, Alleyne C, Walsh E, Leithead A, Habulihaz B, et al. Development of a convenient in vitro gel diffusion model for predicting the in vivo performance of subcutaneous parenteral formulations of large and small molecules. AAPS PharmSciTech. 2017;18:2203\u201313 [cited 2020 Oct 7]. Available from: https:\/\/link.springer.com\/article\/10.1208\/s12249-016-0698-5.","journal-title":"AAPS PharmSciTech"},{"key":"1965_CR40","doi-asserted-by":"publisher","unstructured":"Kurtz A, Pape H-C, Silbernagl S, Bondke Persson A, Brenner B, Burckhardt G, et al. 13 W\u00e4rmehaushalt und Temperaturregulation. Physiologie. 2018.\u00a0https:\/\/doi.org\/10.1055\/b-006-149284.","DOI":"10.1055\/b-006-149284"},{"key":"1965_CR41","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/clpt.1980.46","volume":"27","author":"PA Routledge","year":"1980","unstructured":"Routledge PA, Barchowsky A, Blornsson TD, Kitchell BB, Shand DG. Lidocaine plasma protein binding. Clin Pharmacol Ther. 1980;27:347\u201351 [cited 2020 Aug 19]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/7357791\/.","journal-title":"Clin Pharmacol Ther"},{"key":"1965_CR42","first-page":"17","volume":"64","author":"GJ Szpunar","year":"1989","unstructured":"Szpunar GJ, Albert KS, Wagner JG. Pharmacokinetics of flurbiprofen in man II. Plasma protein binding. Res Commun Chem Pathol Pharmacol. 1989;64:17\u201330.","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"1965_CR43","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.2042-7158.1985.tb05101.x","volume":"37","author":"L Aarons","year":"1985","unstructured":"Aarons L, Khan AZ, Grennan DM, Alam-Siddiqi M. The binding of flurbiprofen to plasma proteins. J Pharm Pharmacol. 1985;37:644\u20136 [cited 2020 Aug 19]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/2867185\/.","journal-title":"J Pharm Pharmacol"},{"key":"1965_CR44","doi-asserted-by":"publisher","unstructured":"Gasmi H, Willart JF, Danede F, Hamoudi MC, Siepmann J, Siepmann F. Importance of PLGA microparticle swelling for the control of prilocaine release. J Drug Deliv Sci Technol. 2015;30:123\u201332.\u00a0https:\/\/doi.org\/10.1016\/j.jddst.2015.10.009.","DOI":"10.1016\/j.jddst.2015.10.009"},{"key":"1965_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jconrel.2019.05.039","volume":"306","author":"C Bode","year":"2019","unstructured":"Bode C, Kranz H, Fivez A, Siepmann F, Siepmann J. Often neglected: PLGA\/PLA swelling orchestrates drug release: HME implants. J Control Release. 2019;306:97\u2013107.","journal-title":"J Control Release"},{"key":"1965_CR46","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jconrel.2015.06.039","volume":"213","author":"H Gasmi","year":"2015","unstructured":"Gasmi H, Danede F, Siepmann J, Siepmann F. Does PLGA microparticle swelling control drug release? New insight based on single particle swelling studies. J Control Release. 2015;213:120\u20137 [cited 2019 Mar 28]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0168365915300110.","journal-title":"J Control Release"},{"key":"1965_CR47","doi-asserted-by":"publisher","unstructured":"Samadi N, Abbadessa A, Di Stefano A, Van Nostrum CF, Vermonden T, Rahimian S, et al. The effect of lauryl capping group on protein release and degradation of poly(d,l-lactic-co-glycolic acid) particles. J Control Release. 2013;172(2):436\u201343.\u00a0https:\/\/doi.org\/10.1016\/j.jconrel.2013.05.034.","DOI":"10.1016\/j.jconrel.2013.05.034"},{"key":"1965_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijpharm.2008.02.012","volume":"358","author":"MA Holgado","year":"2008","unstructured":"Holgado MA, Arias JL, C\u00f3zar MJ, Alvarez-Fuentes J, Ga\u00f1\u00e1n-Calvo AM, Fern\u00e1ndez-Ar\u00e9valo M. Synthesis of lidocaine-loaded PLGA microparticles by flow focusing. Effects on drug loading and release properties. Int J Pharm. 2008;358:27\u201335.","journal-title":"Int J Pharm"},{"key":"1965_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2019.07.013","volume":"308","author":"JV Andhariya","year":"2019","unstructured":"Andhariya JV, Jog R, Shen J, Choi S, Wang Y, Zou Y, et al. Development of Level A in vitro-in vivo correlations for peptide loaded PLGA microspheres. J Control Release. 2019;308:1\u201313.","journal-title":"J Control Release"},{"key":"1965_CR50","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s13346-018-0513-9","volume":"8","author":"P Bhusal","year":"2018","unstructured":"Bhusal P, Rahiri JL, Sua B, McDonald JE, Bansal M, Hanning S, et al. Comparing human peritoneal fluid and phosphate-buffered saline for drug delivery: do we need bio-relevant media? Drug Deliv Transl Res. 2018;8:708\u201318. https:\/\/doi.org\/10.1007\/s13346-018-0513-9.","journal-title":"Drug Deliv Transl Res"},{"key":"1965_CR51","doi-asserted-by":"publisher","first-page":"6089","DOI":"10.1039\/C5AN00921A","volume":"140","author":"SM Fr\u00f6hlich","year":"2015","unstructured":"Fr\u00f6hlich SM, Eilenberg M, Svirkova A, Grasl C, Liska R, Bergmeister H, et al. Mass spectrometric imaging of in vivo protein and lipid adsorption on biodegradable vascular replacement systems. Analyst. 2015;140:6089\u201399.","journal-title":"Analyst"},{"key":"1965_CR52","doi-asserted-by":"publisher","unstructured":"Choi J, Lee BS, Park K, Han DK, Park KD, Kim YH. Beneficial effect of sulfonated peografted polyurethanes on calcification and lipid adsorption of vascular implants. Macromol Res. 2010;18:1133\u20136.\u00a0https:\/\/doi.org\/10.1007\/s13233-010-1112-x.","DOI":"10.1007\/s13233-010-1112-x"},{"key":"1965_CR53","doi-asserted-by":"publisher","first-page":"9723","DOI":"10.1021\/ac5025232","volume":"86","author":"SM Fr\u00f6hlich","year":"2014","unstructured":"Fr\u00f6hlich SM, Archodoulaki V-M, Allmaier G, Marchetti-Deschmann M. MALDI-TOF Mass Spectrometry Imaging Reveals Molecular Level Changes in Ultrahigh Molecular Weight Polyethylene Joint Implants in Correlation with Lipid Adsorption. Anal Chem. 2014;86:9723\u201332 [cited 2020 Sep 13]. Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/ac5025232.","journal-title":"Anal Chem"},{"key":"1965_CR54","doi-asserted-by":"publisher","unstructured":"Menei P, Daniel V, Montero-Menei C, Brouillard M, Pouplard-Barthelaix A, Benoit JP. Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres. Biomaterials. 1993;14(6):470\u20138.\u00a0https:\/\/doi.org\/10.1016\/0142-9612(93)90151-Q.","DOI":"10.1016\/0142-9612(93)90151-Q"},{"key":"1965_CR55","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jbm.820060504","volume":"6","author":"R Carmen","year":"1972","unstructured":"Carmen R, Mutha SC. Lipid absorption by silicone heart valve poppets\u2014in-vivo and in-vitro results. J Biomed Mater Res. 1972;6:327\u201346.","journal-title":"J Biomed Mater Res"},{"key":"1965_CR56","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/jbm.820020406","volume":"2","author":"R Carmen","year":"1968","unstructured":"Carmen R, Kahn P. In vitro testing of silicone rubber heart-valve poppets for lipid absorption. J Biomed Mater Res. 1968;2:457\u201364.","journal-title":"J Biomed Mater Res"},{"key":"1965_CR57","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/jbm.820080603","volume":"8","author":"JW Swanson","year":"1974","unstructured":"Swanson JW, Lebeau JE. The effect of implantation on the physical properties of silicone rubber. J Biomed Mater Res. 1974;8:357\u201367.","journal-title":"J Biomed Mater Res"},{"key":"1965_CR58","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/pharmaceutics11120665","volume":"11","author":"C Janich","year":"2019","unstructured":"Janich C, Friedmann A, Martins de Souza e Silva J, Santos de Oliveira C, de Souza LE, Rujescu D, et al. Risperidone-Loaded PLGA\u2013Lipid Particles with Improved Release Kinetics: Manufacturing and Detailed Characterization by Electron Microscopy and Nano-CT. Pharmaceutics. 2019;11:665 [cited 2021 Jan 25]. Available from: https:\/\/www.mdpi.com\/1999-4923\/11\/12\/665.","journal-title":"Pharmaceutics"},{"key":"1965_CR59","doi-asserted-by":"publisher","unstructured":"Siepmann F, Karrout Y, Gehrke M, Penz FK, Siepmann J. Limited drug solubility can be decisive even for freely soluble drugs in highly swollen matrix tablets. Int J Pharm. 2017;526(1\u20132):280\u201390.\u00a0https:\/\/doi.org\/10.1016\/j.ijpharm.2017.05.001.","DOI":"10.1016\/j.ijpharm.2017.05.001"},{"key":"1965_CR60","doi-asserted-by":"crossref","unstructured":"Siepmann J, Siepmann F. Sink conditions do not guarantee the absence of saturation effects. Int J Pharm. 2020;577 [cited 2020 Sep 9]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31917299\/.","DOI":"10.1016\/j.ijpharm.2019.119009"},{"key":"1965_CR61","doi-asserted-by":"publisher","unstructured":"van der Vusse GJ. Albumin as fatty acid transporter. Drug Metab Pharmacokinet. 2009;24(4):300\u20137.\u00a0https:\/\/doi.org\/10.2133\/dmpk.24.300.","DOI":"10.2133\/dmpk.24.300"},{"key":"1965_CR62","doi-asserted-by":"publisher","unstructured":"Eriksson U, Falkevall A. Visualizing Fatty Acid Flux. 2018;27:1161\u20132. https:\/\/doi.org\/10.1016\/j.cmet.2018.05.017.","DOI":"10.1016\/j.cmet.2018.05.017"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-021-01965-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-021-01965-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-021-01965-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T16:07:51Z","timestamp":1626970071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-021-01965-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1965"],"URL":"https:\/\/doi.org\/10.1208\/s12249-021-01965-4","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]},"assertion":[{"value":"15 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"119"}}